What does CUSIP 74275C205 represent in this 13F holders report?

CUSIP 74275C205 is the security identifier for PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW in Q1 2022?

16 institutional investors reported PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW for Q1 2022. Use the holders table for investor-level position and value details.

PROCESSA PHARMACEUTICALS INC - COM NEW (PCSA)

CUSIP: 74275C205

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / COM NEW
Total 13F shares: 1,070,615
Total 13F value: $3,222,000
Share change: -249,456
SEC-reported price per share: $3.01
Number of holders: 16
Value change: -$900,085
Number of buys: 3
Number of sells: 5

Security key

74275C205

Report period

Q1 2022

Institutions

Top holders

PCSA full security history Ownership snapshot Full 13F holder table Processa Pharmaceuticals, Inc. SEC filings Processa Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of PCSA - PROCESSA PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

VANGUARD GROUP INC

Comparable rows

0/15

Latest evidence

31 Dec 2021

13F Highest disclosed value: $1,830,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $1.83M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Disclosed position value Top 5

VANGUARD GROUP INC $1.83M

AIGH Capital Management LLC $1.49M

Solas Capital Management, LLC $961K

ESSEX INVESTMENT MANAGEMENT CO LLC $359K

Worth Venture Partners, LLC $348K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$1,830,000 373,598 shares	—	31 Dec 2021
AIGH Capital Management LLC	13F Company 13F	— denominator unverified	$1,488,000 303,703 shares	—	31 Dec 2021
Solas Capital Management, LLC	13F Company 13F	— denominator unverified	$961,000 196,150 shares	—	31 Dec 2021
ESSEX INVESTMENT MANAGEMENT CO LLC	13F Company 13F	— denominator unverified	$359,000 73,180 shares	—	31 Dec 2021
Worth Venture Partners, LLC	13F Company 13F	— denominator unverified	$348,000 70,954 shares	—	31 Dec 2021
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$318,000 64,902 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,070,615

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %